Hexafluoroisopropanol-Induced Facial Selectivity in a Hindered Diels–Alder Reaction

David J. P. Kornfilt; Brian T. Chamberlain; Isabelle Chataigner; Riccardo Spezia; Florence F. Wagner

doi:10.1055/a-2016-4548

Synthesis, Inhaltsverzeichnis

Synthesis 2023; 55(13): 2047-2052
DOI: 10.1055/a-2016-4548

paper

Hexafluoroisopropanol-Induced Facial Selectivity in a Hindered Diels–Alder Reaction

David J. P. Kornfilt ‡

^aCenter for the Development of Therapeutics, Broad Institute of MIT and Harvard, 415 Main St, Cambridge, MA 02142, USA

,

Brian T. Chamberlain‡

^aCenter for the Development of Therapeutics, Broad Institute of MIT and Harvard, 415 Main St, Cambridge, MA 02142, USA

,

Isabelle Chataigner

^bSorbonne Université, CNRS, Laboratoire de Chimie Théorique, LCT, 75005 Paris, France

^cNormandie Université, UNIROUEN, CNRS, INSA Rouen, COBRA Laboratory, 76000 Rouen, France

,

Riccardo Spezia

^bSorbonne Université, CNRS, Laboratoire de Chimie Théorique, LCT, 75005 Paris, France

,

Florence F. Wagner∗

^aCenter for the Development of Therapeutics, Broad Institute of MIT and Harvard, 415 Main St, Cambridge, MA 02142, USA

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

BRD4780 is a small molecule that can selectively clear mutant MUC1-fs protein in mucin kidney disease models. Prior syntheses of BRD4780 were unsuitable for preparation on large scale. In this manuscript, HFIP is described as a unique solvent that allowed the key Diels–Alder reaction to proceed with >20:1 endo diastereoselectivity, enabling the kg-scale preparation of BRD4780 for further studies.

Key words

Diels–Alder reaction - nitroalkene - BRD4780 - mucin-1 kidney disease - HFIP

Volltext

Referenzen

References

1a Hubbard RD, Miller BL. J. Org. Chem. 1998; 63: 4143
1b Nicolaou KC, Snyder SA, Montagnon T, Vassilikogiannakis G. Angew. Chem. Int. Ed. 2002; 41: 1668
1c Corey EJ, Guzman-Perez A. Angew. Chem. Int. Ed. 1998; 37: 388

2 Lam Y.-h, Cheong PH.-Y, Blasco Mata JM, Stanway SJ, Gouverneur V, Houk KN. J. Am. Chem. Soc. 2009; 131: 1947
3 Dvela-Levitt M, Shaw JL, Greka A. Trends Mol. Med. 2021; 27: 394
4 Munk SA, Lai RK, Burke JE, Arasasingham PN, Kharlamb AB, Manlapaz CA, Padillo EU, Wijono MK, Hasson DW, Wheeler LA, Garst ME. J. Med. Chem. 1996; 39: 1193
5 Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, Johnston SE, Vrcic A, Wong B, Khan M, Asiedu J, Narayan R, Mader CC, Subramanian A, Golub TR. Nat. Med. 2017; 23: 405
6 Dvela-Levitt M, Kost-Alimova M, Emani M, Kohnert E, Thompson R, Sidhom EH, Rivadeneira A, Sahakian N, Roignot J, Papagregoriou G, Montesinos MS, Clark AR, McKinney D, Gutierrez J, Roth M, Ronco L, Elonga E, Carter TA, Gnirke A, Melanson M, Hartland K, Wieder N, Hsu JC, Deltas C, Hughey R, Bleyer AJ, Kmoch S, Živná M, Barešova V, Kota S, Schlondorff J, Heiman M, Alper SL, Wagner F, Weins A, Golub TR, Lander ES, Greka A. Cell 2019; 178: 521-535.e23
7 Takenaka N, Sarangthem RS, Seerla SK. Org. Lett. 2007; 9: 2819
8 Wittkopp A, Schreiner PR. Chem. Eur. J. 2003; 9: 407
9 Denmark SE, Cramer CJ, Sternberg JA. Helv. Chim. Acta 1986; 69: 1971
10 Denmark SE, Moon YC, Senanayake CB. W. J. Am. Chem. Soc. 1990; 112: 311
11 Çelebi-Ölçüm N, Ess DH, Aviyente V, Houk KN. J. Am. Chem. Soc. 2007; 129: 4528
12 Ruiz-Lopez MF, Assfeld X, Garcia JI, Mayoral JA, Salvatella L. J. Am. Chem. Soc. 1993; 115: 8780
13 Cativiela C, García JI, Mayoral JA, Salvatella L. Can. J. Chem. 1994; 72: 308
14 Cativiela C, García JI, Gil J, Martínez RM, Mayoral JA, Salvatella L, Urieta JS, Mainar AM, Abraham MH. J. Chem. Soc., Perkin Trans. 2 1997; 653
15 Motiwala HF, Armaly AM, Cacioppo JG, Coombs TC, Koehn KR. K, Norwood VM. IV, Aubé J. Chem. Rev. 2022; 122: 12544
16 Jasiński R, Koifman O, Barański A. Open Chem. 2011; 9: 1008
17 Yang Y.-F, Yu P, Houk KN. J. Am. Chem. Soc. 2017; 139: 18213

Zusatzmaterial

Supporting Information